Single-cell RNA sequencing reveals key signaling pathways and biological functions in giant cell tumors of bone
Lin Zhong,
No information about this author
Zuoxi Chen
No information about this author
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: April 19, 2025
Language: Английский
Rocaglamide Suppresses Allergic Reactions by Regulating IL-4 Receptor Signaling
Hyein Jo,
No information about this author
Mi‐Sun Kim,
No information about this author
Jaewhoon Jeoung
No information about this author
et al.
Molecules,
Journal Year:
2025,
Volume and Issue:
30(4), P. 840 - 840
Published: Feb. 11, 2025
Rocaglamide
(Roc-A),
a
natural
phytochemical
isolated
from
Aglaia
species,
is
known
to
exert
anticancer
effects.
Allergic
inflammation
can
enhance
the
tumorigenic
potential
of
cancer
cells.
We
hypothesized
that
Roc-A
could
regulate
allergic
inflammation.
prevented
an
antigen
increasing
hallmarks
reactions
in
vitro.
suppressed
passive
cutaneous
anaphylaxis
(PCA)
and
systemic
(PSA).
RNA
sequencing
analysis
showed
expression
IL-4
RBL2H3
also
interleukin-4
receptor
(IL-4R).
was
found
form
hydrogen-bonding
network
with
residues
N92
L64
IL-4R
molecular
docking
simulation.
inducing
binding
JAK1.
Chromatin
immunoprecipitation
(ChIP)
assays
C-Jun
bind
promoter
sequences
IL-4R.
Mouse
recombinant
protein
increased
β-hexosaminidase
activity,
expression,
antigen-independent
manner.
expressions
CD163
arghinase-1
markers
M2
macrophages,
but
decreased
iNOS,
marker
M1
macrophages
lung
macrophages.
regulated
effects
culture
medium
antigen-stimulated
cells
on
iNOS
arginase-1
RAW264.7
The
blocking
or
downregulation
exerted
negative
PCA,
PSA.
An
miR-34a
mimic
decreasing
identified
chemicals
via
analysis.
chemical
1536801
activity
reactions.
effect
PCA.
TargetScan
predicted
as
regulator
anti-allergic
its
mechanisms
were
associated
miR-34a.
Taken
together,
our
results
show
understanding
IL-4R-mediated
provide
clues
for
development
anti-allergy
therapeutics.
Language: Английский
Unraveling heterogeneity and treatment of asthma through integrating multi-omics data
Wei Zhang,
No information about this author
Yu Zhang,
No information about this author
Lifei Li
No information about this author
et al.
Frontiers in Allergy,
Journal Year:
2024,
Volume and Issue:
5
Published: Nov. 5, 2024
Asthma
has
become
one
of
the
most
serious
chronic
respiratory
diseases
threatening
people's
lives
worldwide.
The
pathogenesis
asthma
is
complex
and
driven
by
numerous
cells
their
interactions,
which
contribute
to
its
genetic
phenotypic
heterogeneity.
clinical
characteristic
insufficient
for
precision
patient
classification
therapies;
thus,
a
combination
functional
or
pathophysiological
mechanism
phenotype
proposes
new
concept
called
“asthma
endophenotype”
representing
various
subtypes
defined
distinct
mechanisms.
High-throughput
omics
approaches
including
genomics,
epigenomics,
transcriptomics,
proteomics,
metabolomics
microbiome
enable
us
investigate
pathogenetic
heterogeneity
diverse
endophenotypes
underlying
mechanisms
from
different
angles.
In
this
review,
we
provide
comprehensive
overview
roles
cell
types
in
pathophysiology
present
current
perspective
on
contribution
into
bidirectional
interaction
between
airway
inflammation
remodeling.
We
next
discussed
how
integrated
analysis
multi-omics
data
via
machine
learning
can
systematically
characterize
molecular
biological
profiles
phenotype.
application
stratification
therapies
will
be
described.
Integrating
more
insights
key
pathogenic
reshape
strategies
management
treatment.
Language: Английский
Deciphering the pharmacological mechanism of Radix astragali for allergic rhinitis through network pharmacology and experimental validation
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Dec. 2, 2024
Radix
Astragali
(RA)
has
been
recognized
for
its
therapeutic
potential
in
allergic
rhinitis
(AR),
yet
pharmacological
mechanisms
remain
elusive.
This
study
systematically
investigated
the
physicochemical
properties
and
biological
activities
of
RA's
phytochemicals,
aiming
to
elucidate
their
targets
AR
treatment.
We
identified
775
key
phytochemicals
intersected
these
with
29,544
AR-related
disease
targets,
pinpointing
747
shared
targets.
A
protein-protein
interaction
network
analysis
categorized
into
five
subclusters,
TNF,
NFKB1,
IKBKB,
NFKBIA,
CHUK
emerging
as
central
nodes.
Enrichment
revealed
roles
inflammatory
immune
responses,
particularly
through
NF-κB,
IL-17,
Toll-like
receptor,
NOD-like
receptor
signaling
pathways.
Molecular
docking
dynamics
simulations
confirmed
strong
binding
affinity
stability
In
vivo,
RA
intervention
effectively
reversed
expression
markers
an
IL-13-induced
nasal
mucosa
inflammation
model.
Our
findings
suggest
that
multitargeted
approach
involves
modulation
critical
pathways,
highlighting
potential.
Language: Английский
Single-Cell Analysis: A Method for In-Depth Phenotyping of Cells Involved in Asthma
Daniel Rodríguez-González,
No information about this author
Gema Guillén-Sánchez,
No information about this author
Victoria del Pozo
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(23), P. 12633 - 12633
Published: Nov. 25, 2024
Asthma
is
a
chronic
inflammatory
lung
disease
with
high
prevalence,
making
it
one
of
the
most
common
conditions
worldwide.
Its
pathophysiology
influenced
by
range
genetic
and
environmental
factors,
resulting
in
complex
heterogeneous
profile.
primarily
associated
type
2
(T2)
immune
response,
though
non-T2
endotypes
also
contribute
to
pathology.
Generally,
asthma
characterized
infiltration
activation
various
cell
types,
including
dendritic
cells,
eosinophils,
innate
lymphoid
lymphocytes,
mast
neutrophils,
which
participate
T1,
T2,
T17
responses.
Despite
advances
understanding,
many
questions
remain
unresolved.
Therefore,
emerging
omic
techniques,
such
as
single-cell
RNA
sequencing
(scRNA-seq),
offer
novel
insights
into
underlying
mechanisms
roles
these
cells.
Recent
scRNA-seq
studies
have
identified
multiple
subtypes
clusters,
suggesting
their
potential
functions
The
rapid
advancement
technology
now
enables
in-depth
investigation
individual
cells
within
tissues,
allowing
for
precise
cell-type
classification
detailed
molecular
profiling.
Nonetheless,
certain
limitations
persist,
require
further
refinement
future
studies.
Language: Английский
Content of Th17 related and Th2 cytokines in asthma patients with cold airway hyperresponsiveness
Medical Immunology (Russia),
Journal Year:
2024,
Volume and Issue:
27(2), P. 351 - 360
Published: Oct. 7, 2024
The
phenomenon
of
cold
airway
hyperresponsiveness
is
rather
common
among
patients
with
bronchial
asthma.
Possible
participation
immune
mechanisms
in
its
occurence
scarcely
studied.
In
particular,
there
no
information
about
interaction
between
Th17-related
cytokines,
and
cytokines
Th2
response
related
to
inflammation
asthma
cold-induced
bronchospasm.Our
objective
was
evaluate
the
contents
IL-17A,
IL-6,
IL-22,
IL-4
IL-13
interleukins
patients,
specify
their
role
formation
hyperresponsiveness.
Spirometric
indices
forced
expiratory
flow
were
measured
43
content
blood
serum
estimated
before
after
bronchoprovocation
test
3-min.
isocapnic
hyperventilation
(-20
°C)
air.
Two
groups
formed
presence
(group
1,
n
=
14)
absence
2,
29)
hyperresponsiveness,
verified
by
degree
volume
reduction
per
1
sec.
(∆FFV
1ihca
)
(-16.5
(-20.0
–
-12.0)%
-2.3
(-3.5
-0.8)%,
respectively;
p
<
0.0001).
group
when
compared
lower
baseline
values
FEV
(88.1±3.1%
96.6±2.2%,
0.044),
midexpiratory
(MEF
25-75
62.4±3.87%
75.6±3.7%,
0.013)
registered.
Moreover,
subjects
significantly
higher
than
who
did
not
respond
There
a
correlation
IL-17A
severity
reaction
(∆FEV
(Rs
-0.33;
0.049).
high
IL-6
suggest
both
Th1/Th17
regulation
bronchospasm
development
“Th2
low”
subtype.
Language: Английский